18B.6Potential negative impacts

Material under review: November 2017     

Suggested citation: Greenhalgh, EM, & Scollo, MM. InDepth 18B: Electronic cigarettes (e-cigarettes). In Scollo, MM and Winstanley, MH [editors]. Tobacco in Australia: Facts and issues. Melbourne: Cancer Council Victoria; 2017. Available from: http://www.tobaccoinaustralia.org.au/chapter-18-harm-reduction/indepth-18b-e-cigarettes

At the heart of the debate over the utility of e-cigarettes is concern about the extent to which the potential benefits of making a likely-less harmful alternative to tobacco widely available to smokers might be outweighed by several potential risks. Risks identified to date include uptake by non-smokers, gateway effects, dangers associated with dual use, discouragement from cessation, renormalising smoking, and allowing the tobacco industry to influence decision-making in public health.1-3

18B.6.1.Uptake among non-smokers and a ‘gateway effect’ to tobacco smoking

Experimentation with e-cigarettes among non-smoking adults appears to be relatively rare.4, 5  Among young people however, use is increasing, in some countries quite rapidly (see Section 18B.3). While initial reports indicated that e-cigarette use occurred predominantly among adolescents who had also experimented with tobacco,6 more recent data shows increasing use among never smokers.7 An analysis of trends from 2011 to 15 in e-cigarette use among US adolescents found that over time, past month e-cigarette users increasingly encompassed those who were not users of other tobacco products.8 In 2016 in the US, e-cigarettes remained the most commonly used tobacco-related product among students.9

Of great concern to public health experts is the growing body of research suggesting a possible relationship between e-cigarette use and the uptake and escalation of smoking among young people.  A large longitudinal study of Californian high school students has suggested that e-cigarettes are attracting users who would not have taken up combustible tobacco products.7 A number of studies in the US have observed an association between e-cigarette use and intention/willingness to smoke in the future,10-12 and subsequent tobacco use.13-19 A 2016 meta-analysis concluded that never-smoking adolescents and young adults who use e-cigarettes are more likely to intend to smoke,20 and a systematic review in the same year concluded that e-cigarette use is associated with an increase in smoking, even among adolescents not susceptible to smoking.21 A more recent study in the UK found a robust relationship between ever-use of e-cigarettes and subsequent uptake of smoking among adolescents, and weaker evidence of a relationship between e-cigarette use and increasing consumption of conventional cigarettes.22   

Such studies cannot establish causation (i.e., vaping could be a marker in young people who would have gone onto use conventional cigarettes regardless; one cannot rule out the possibility that the relationship between e-cigarette use and smoking is explained by another/other variable/s). However several studies have noted conventional cigarette uptake among e-cigarette users who would be considered least at risk of smoking,13, 21, 22 and the best-quality studies and reviews have attempted to control for underlying susceptibility. Several possible mechanisms of how vaping may act as a ‘gateway’ to smoking have been proposed. E-cigarette use could normalise nicotine use and smoking behaviours more generally, leading to the renormalisation of smoking, or it could cause users to develop nicotine addiction.20, 22   

Regardless of whether they go on to be smokers, use of e-cigarettes by children is a concern to public health specialists and regulators. Exposure to nicotine during adolescence may have significant and lasting health consequences,23 including long-term addiction to e-cigarette delivered nicotine.24 Further, although the adverse health effects of e-cigarette use are likely less than those of cigarettes, the long-term consequences are not well understood. Limited evidence suggests that vaping—particularly when e-liquids include sweet flavourings25, 26 —may increase users’ risks of cardiovascular and respiratory disease (see Section 18B.5). Some adolescents are also using e-cigarettes for vaping of cannabis and other substances which pose additional risks.27   

As with tobacco cigarettes, exposure to e-cigarette marketing and promotion is associated with greater e-cigarette use among young people,28-31 with ads for flavoured e-cigarettes potentially being more appealing to children than those for non-flavoured products32 (see Section 18B.2.3). Along with curiosity, the wide range of fruit, candy, and other sweet flavours is one of the most commonly cited reasons for experimentation among children.33-36 Although such flavours have been banned in conventional cigarettes in Australia (except WA)37-43 and the US44 largely due to their appeal to children, and despite the high levels of toxic compounds found in flavoured e-cigarettes,45, 46 it has been estimated that there are over 7500 different flavours of e-liquid available.47

Together, these issues have led to calls for strict regulations that would minimise use among young people and non-smokers, including restrictions on advertising and promotion, prohibiting use in smokefree areas, banning flavours that could appeal to youth, raising taxes, implementing health warnings, and prohibiting sales to minors.48, 49   

18B.6.2 Prolonged dual use 

Dual use refers to the concurrent use of conventional tobacco products and e-cigarettes.  Dual use is actively promoted by some e-cigarette manufacturers, especially those that also manufacture tobacco products, as a way for smokers to by-pass smokefree regulations.50 Other smokers use both products as a means of reducing their exposure to tobacco smoke, and/or as an intended pathway to smoking cessation.51 A 2016 meta-analysis concluded that cigarette smoking increases the probability of e-cigarette use, especially among current smokers and adolescents.52

While a reduction in risk seems likely for smokers who completely substitute tobacco cigarettes,53, 54 the benefits for those who continue to use some tobacco cigarettes are much less certain. Among those who exclusively smoke tobacco cigarettes, cutting down the number of cigarettes consumed may not reduce toxic exposure if smokers compensate by drawing more deeply on the cigarettes they do smoke. There is some evidence that supplementing reduced cigarette consumption with an alternative source of nicotine might reduce toxicant exposure and hence mortality among smokers who continue to smoke at a reduced rate—see section 18B.7.3.55-57 However, there are no long-term studies to measure whether long-term dual use translates into measurably better health outcomes compared to continued smoking of cigarettes alone.

18B.6.3 Discouragement from cessation

Smokers taking up e-cigarettes while still smoking tobacco cigarettes, who might otherwise have quit altogether had they not commenced e-cigarette use, might represent missed opportunities for complete cessation. So far, research on the likelihood of dual use of cigarettes and e-cigarettes prompting or supporting cessation is limited.  While cutting down cigarettes has been associated with later increased success in quitting, the evidence for improved cessation rates among those who supplement tobacco cigarettes with e-cigarettes is mixed. Evidence to date suggests that smokers who use e-cigarette intensively may be more likely to quit conventional cigarettes,58-61 however intermittent users—who comprise the majority of users—may be less likely to quit58, 61 (see Section 18B.7).

Smoking poses a very significant risk to health both in the immediate and the longer term, but the most serious diseases emerge only with long-term use. While two of every three long term smokers in Australia will die from smoking, quitting prior to age 45 reduces mortality risk close to that of never smokers.62 Given that complete cessation of use of any nicotine product is the option associated with least harm, it follows that the optimal approach for younger smokers at least in the first instance would be to attempt to quit without continuing use of nicotine. 

18B.6.4 The renormalisation of smoking 

Decades of successful public health campaigning have profoundly denormalised smoking. As evidence has accumulated about the hazards of tobacco to smokers and non-smokers alike, stronger public health measures—including restrictions on smoking—have been widely adopted.63 Those advocating caution about e-cigarettes have characterised these new products as having the potential to weaken these tobacco control efforts and help to renormalise smoking, particularly if they are used in smokefree areas.63, 64   

It has also been argued that e-cigarettes could revive the behaviour of smoking in public, undermining increasingly stringent restrictions on smoking in both indoor and outdoor areas.1 Along with cessation, a study of older adults in the US found that they reported using e-cigarettes as a way to circumvent no-smoking policies, and perceived e-cigarette marketing as a way to renormalise smoking.65 An alternative view is that e-cigarettes are easily distinguishable in appearance and smell from tobacco cigarettes, and that widespread use of e-cigarettes is more likely to normalise alternative nicotine devices than smoking, and may benefit and support smokefree environments.6  

18B.6.5 Potential to reinvolve the tobacco industry in public health policy 

Although e-cigarettes were originally developed and marketed independently from the tobacco industry, some of the world’s largest tobacco companies have  come to dominate the market—see Section 18B.1.3. Given its history of unethically promoting and defending tobacco cigarettes, the tobacco industry’s involvement in e-cigarettes is of great concern to public health experts. The tobacco industry is said to be pursuing five goals: promoting widespread dual use; hindering smoking cessation; renormalising public smoking; conveying to young people that nicotine is a benign drug; and welcoming back lapsed smokers.1 Concerns have also been raised regarding the quality of research on e-cigarettes, with one systematic review finding many serious methodological shortcomings. In 34% of the papers reviewed, the authors had a conflict of interest. Most studies were funded or otherwise supported/influenced by manufacturers of e-cigarettes, which appeared to influence the conclusions of the papers.66

As well as enjoying commercial gains from investing in e-cigarettes, it has been argued that tobacco companies are likely to be keen to exploit opportunities for advertising and promotion that will promote tobacco and/or e-cigarette use. By becoming involved in alternative nicotine delivery products, companies may be able to evade current restrictions on engagement in policy imposed by Article 5.3 of the Framework Convention on Tobacco Control (FCTC).6 In response to concerns regarding the possibility of e-cigarettes interfering with existing tobacco control efforts, the WHO has invited FCTC Parties to “protect tobacco-control activities from all commercial and other vested interests related to [electronic nicotine delivery systems], including interests of the tobacco industry”.67   


Recent news and research

For recent news items and research on this topic, click here (Last updated March 2018)  



1. Chapman S. Should electronic cigarettes be as freely available as tobacco cigarettes? No. British Medical Journal, 2013; 346:f3840. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23771038

2. Etter JF. Should electronic cigarettes be as freely available as tobacco? Yes. British Medical Journal, 2013; 346:f3845. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23771039

3. Kalkhoran S and Glantz SA. Modeling the health effects of expanding e-cigarette sales in the United States and United Kingdom: A monte carlo analysis. JAMA Internal Medicine, 2015. Available from: http://dx.doi.org/10.1001/jamainternmed.2015.4209

4. Hajek P, Etter JF, Benowitz N, Eissenberg T, and McRobbie H. Electronic cigarettes: Review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction, 2014; 109(11):1801–10. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25078252

5. Australian Institute of Health and Welfare. National Drug Strategy Household Survey detailed report: 2013. Cat. no. PHE 183 Canberra: AIHW, 2014. Available from: http://www.aihw.gov.au/publication-detail/?id=60129549469&tab=3.

6. Britton J and Bogdanovica I. Electronic cigarettes: A report commissioned by Public Health England.  2014. Available from:https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/311887/Ecigarettes_report.pdf.

7. Barrington-Trimis JL, Urman R, Leventhal AM, Gauderman WJ, Cruz TB, et al. E-cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics, 2016; 138(2). Available from: http://www.ncbi.nlm.nih.gov/pubmed/27401102

8. Chaffee BW, Couch ET, and Gansky SA. Trends in characteristics and multi-product use among adolescents who use electronic cigarettes, United States 2011-2015. PLoS ONE, 2017; 12(5):e0177073. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28475634

9. Jamal A, Gentzke A, and Hu S. Tobacco use among middle and high school students—United States, 2011–2016. Morbidity and Mortality Weekly Report, 2017; 66:597–603. Available from: http://dx.doi.org/10.15585/mmwr.mm6623a1

10. Park JY, Seo DC, and Lin HC. E-cigarette use and intention to initiate or quit smoking among US youths. American Journal of Public Health, 2016; 106(4):672–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26794178

11. Wills TA, Sargent JD, Knight R, Pagano I, and Gibbons FX. E-cigarette use and willingness to smoke: A sample of adolescent non-smokers. Tobacco Control, 2016; 25(e1):e52–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26261237

12. McCabe SE, Veliz P, McCabe VV, and Boyd CJ. Smoking behaviors and intentions among current e-cigarette users, cigarette smokers, and dual users: A national survey of u.S. High school seniors. Preventive Medicine, 2017; 99:228–35. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28257785

13. Barrington-Trimis JL, Urman R, Berhane K, Unger JB, Cruz TB, et al. E-cigarettes and future cigarette use. Pediatrics, 2016; 138(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/27296866

14. Primack BA, Soneji S, Stoolmiller M, Fine MJ, and Sargent JD. Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatrics, 2015; 169(11):1018–23. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26348249

15. Cardenas VM, Evans VL, Balamurugan A, Faramawi MF, Delongchamp RR, et al. Use of electronic nicotine delivery systems and recent initiation of smoking among US youth. International Journal of Public Health, 2016; 61(2):237–41. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26833307

16. Wills TA, Sargent JD, Gibbons FX, Pagano I, and Schweitzer R. E-cigarette use is differentially related to smoking onset among lower risk adolescents. Tobacco Control, 2016; 26(5):534–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27543564

17. Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. Journal of the American Medical Association, 2015; 314(7):700–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26284721

18. Doran N, Brikmanis K, Petersen A, Delucchi K, Al-Delaimy WK, et al. Does e-cigarette use predict cigarette escalation? A longitudinal study of young adult non-daily smokers. Preventive Medicine, 2017; 100:279–84. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28583658

19. Spindle TR, Hiler MM, Cooke ME, Eissenberg T, Kendler KS, et al. Electronic cigarette use and uptake of cigarette smoking: A longitudinal examination of u.S. College students. Addictive Behaviors, 2017; 67:66–72. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28038364

20. Zhong J, Cao S, Gong W, Fei F, and Wang M. Electronic cigarettes use and intention to cigarette smoking among never-smoking adolescents and young adults: A meta-analysis. International Journal of Environmental Research and Public Health, 2016; 13(5). Available from: https://www.ncbi.nlm.nih.gov/pubmed/27153077

21. Chatterjee K, Alzghoul B, Innabi A, and Meena N. Is vaping a gateway to smoking: A review of the longitudinal studies. International Journal of Adolescent Medicine and Health, 2016. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27505084

22. Conner M, Grogan S, Simms-Ellis R, Flett K, Sykes-Muskett B, et al. Do electronic cigarettes increase cigarette smoking in UK adolescents? Evidence from a 12-month prospective study. Tobacco Control, 2017. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28818839

23. England LJ, Bunnell RE, Pechacek TF, Tong VT, and McAfee TA. Nicotine and the developing human: A neglected element in the electronic cigarette debate. American Journal of Preventive Medicine, 2015; 49(2):286–93. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25794473

24. Klein JD. Electronic cigarettes are another route to nicotine addiction for youth. JAMA Pediatrics, 2015; 169(11):993–4. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26349006

25. Leigh NJ, Lawton RI, Hershberger PA, and Goniewicz ML. Flavourings significantly affect inhalation toxicity of aerosol generated from electronic nicotine delivery systems (ends). Tobacco Control, 2016; 25(Suppl 2):ii81–ii7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27633767

26. Tierney PA, Karpinski CD, Brown JE, Luo W, and Pankow JF. Flavour chemicals in electronic cigarette fluids. Tobacco Control, 2016; 25(e1):e10–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25877377

27. Moore G, Hewitt G, Evans J, Littlecott HJ, Holliday J, et al. Electronic-cigarette use among young people in Wales: Evidence from two cross-sectional surveys. BMJ Open, 2015; 5(4):e007072. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25877272

28. Singh T, Agaku IT, Arrazola RA, Marynak KL, Neff LJ, et al. Exposure to advertisements and electronic cigarette use among US middle and high school students. Pediatrics, 2016; 137(5). Available from: https://www.ncbi.nlm.nih.gov/pubmed/27244815

29. Mantey DS, Cooper MR, Clendennen SL, Pasch KE, and Perry CL. E-cigarette marketing exposure is associated with e-cigarette use among US youth. The Journal of Adolescent Health, 2016; 58(6):686–90. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27080732

30. Best C, Haseen F, van der Sluijs W, Ozakinci G, Currie D, et al. Relationship between e-cigarette point of sale recall and e-cigarette use in secondary school children: A cross-sectional study. BMC Public Health, 2016; 16(1):310. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27075888

31. Pu J and Zhang X. Exposure to advertising and perception, interest, and use of e-cigarettes among adolescents: Findings from the US National Youth Tobacco Survey. Perspectives in Public Health, 2017; 137(6):322–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28379069

32. Vasiljevic M, Petrescu DC, and Marteau TM. Impact of advertisements promoting candy-like flavoured e-cigarettes on appeal of tobacco smoking among children: An experimental study. Tobacco Control, 2016; 25(e2):e107–e12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26781305

33. Measham F, O’Brien K, and Turnbull G. “Skittles & red bull is my favourite flavour”: E-cigarettes, smoking, vaping and the changing landscape of nicotine consumption amongst British teenagers – implications for the normalisation debate. Drugs: Education, Prevention and Policy, 2016; 23(3):224–37. Available from: http://dx.doi.org/10.1080/09687637.2016.1178708

34. Kong G, Morean ME, Cavallo DA, Camenga DR, and Krishnan-Sarin S. Reasons for electronic cigarette experimentation and discontinuation among adolescents and young adults. Nicotine & Tobacco Research, 2015; 17(7):847–54. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25481917

35. Harrell MB, Weaver SR, Loukas A, Creamer M, Marti CN, et al. Flavored e-cigarette use: Characterizing youth, young adult, and adult users. Preventive Medicine Reports, 2017; 5:33–40. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27896041

36. Pepper JK, Ribisl KM, and Brewer NT. Adolescents' interest in trying flavoured e-cigarettes. Tobacco Control, 2016; 25(Suppl 2):ii62–ii6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27633762

37. Tobacco and Other Smoking Products Act 1927 (ACT). s 21. See notice contained in Tobacco (Prohibited Smoking Products) Declaration 2011 (No 1) (Notifiable instrument NI2011-584). 

38. Public Health (Tobacco) Act 2008 (NSW). s 29. See notice contained in New South Wales Government Gazette dated 15 January 2010, at 136. 

39. Tobacco and other Smoking Products Act 1998 (QLD). S 26zt. 

40. Tobacco Products Regulation Act 1997 (SA). s 34A. See notice contained in South Australian Government Gazette dated 10 August 2006, at 2640. 

41. Public Health Act 1997 (TAS). s 68A(c)-(e). 

42. Victorian Government Gazette No S 350. Order under section 15N of the Tobacco Act 1987: Banning the sale of certain products. 21 October 2011. Available from: http://www.gazette.vic.gov.au/gazette/Gazettes2011/GG2011S350.pdf

43. Tobacco Control Act, 2002 (NT). Available from: http://www.austlii.edu.au/au/legis/nt/consol_act/tca163/index.html - s6

44. US Food and Drug Administration. Family Smoking Prevention and Tobacco Control Act. 2015. Available from: http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm246129.htm

45. Farsalinos KE, Kistler KA, Gillman G, and Voudris V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine & Tobacco Research, 2015; 17(2):168–74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25180080

46. Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, et al. Flavoring chemicals in e-cigarettes: Diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environmental Health Perspectives, 2016; 124(6):733–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26642857

47. Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, et al. Four hundred and sixty brands of e-cigarettes and counting: Implications for product regulation. Tobacco Control, 2014; 23 Suppl 3:iii3–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24935895

48. Lindblom EN. Effectively regulating e-cigarettes and their advertising—and the first amendment. Food & Drug Law Journal, 2015; 70:57–94. Available from: http://www.law.georgetown.edu/oneillinstitute/news/documents/March10-LindblomFDLJ_001.pdf

49. Krawitz M. We didn't start this fireless vapour: E-cigarette legislation in Australia. J Law Med, 2014; 22(2):462–81. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25715544

50. Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, et al. Four hundred and sixty brands of e-cigarettes and counting: Implications for product regulation. Tobacco Control, 2014; 23 Suppl 3(suppl 3):iii3–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24935895

51. Rahman MA, Hann N, Wilson A, and Worrall-Carter L. Electronic cigarettes: Patterns of use, health effects, use in smoking cessation and regulatory issues. Tobacco Induced Diseases, 2014; 12(1):21. Available from: http://www.biomedcentral.com/content/pdf/1617-9625-12-21.pdf

52. Wang M, Wang JW, Cao SS, Wang HQ, and Hu RY. Cigarette smoking and electronic cigarettes use: A meta-analysis. International Journal of Environmental Research and Public Health, 2016; 13(1). Available from: https://www.ncbi.nlm.nih.gov/pubmed/26771624

53. Farsalinos KE and Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Ther Adv Drug Saf, 2014; 5(2):67–86. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25083263

54. Oh AY and Kacker A. Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes? Review on e-cigarette vapor versus tobacco smoke. Laryngoscope, 2014; 124(12):2702–6. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25302452

55. Chapman S. E-cigarettes: The best and the worst case scenarios for public health-an essay by simon chapman. British Medical Journal, 2014; 349:g5512. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25204397

56. Hart C, Gruer L, and Bauld L. Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland. American Journal of Epidemiology, 2013; 178(5):770–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23825165

57. Tverdal A and Bjartveit K. Health consequences of reduced daily cigarette consumption. Tobacco Control, 2006; 15(6):472–80. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17130377

58. Biener L and Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: Association with smoking cessation and motivation to quit. Nicotine & Tobacco Research, 2015; 17(2):127–33. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25301815

59. Delnevo CD, Giovenco DP, Steinberg MB, Villanti AC, Pearson JL, et al. Patterns of electronic cigarette use among adults in the United States. Nicotine & Tobacco Research, 2016; 18(5):715–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26525063

60. Hitchman SC, Brose LS, Brown J, Robson D, and McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: Findings from a longitudinal online panel survey in Great Britain. Nicotine & Tobacco Research, 2015; 17(10):1187–94. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25896067

61. Giovenco DP and Delnevo CD. Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers. Addictive Behaviors, 2018; 76:129–34. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28802179

62. Banks E, Joshy G, Weber MF, Liu B, Grenfell R, et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: Findings from a mature epidemic with current low smoking prevalence. BMC Medicine, 2015; 13:38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25857449

63. Fairchild AL, Bayer R, and Colgrove J. The renormalization of smoking? E-cigarettes and the tobacco "endgame". New England Journal of Medicine, 2014; 370(4):293–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24350902

64. World Health Organization (WHO), Electronic nicotine delivery systems. Conference of the parties to the who framework convention on tobacco control Moscow, Russian Federation 2014. Available from: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf?ua=1.

65. Cataldo JK, Petersen AB, Hunter M, Wang J, and Sheon N. E-cigarette marketing and older smokers: Road to renormalization. American Journal of Health Behavior, 2015; 39(3):361–71. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25741681

66. Pisinger C and Dossing M. A systematic review of health effects of electronic cigarettes. Preventive Medicine, 2014; 69(0):248–60. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25456810

67. World Health Organization. Conference of the parties to the framework convention on tobacco control. Second report of Committee A. FCTC/COP/6/A/R/2, 2014. Available from: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_AR2-en.pdf


      Previous Chapter Next Chapter